BMEA · Biomea Fusion Inc
United States · RS rating 5 · As of 2026-10-14
| Price | 0.83 USD |
|---|---|
| 1-day change | -33.8% |
| RS rating (overall / 1M / 3M / 12M) | 5 / 2 / 10 / 14 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 33 / 17 / 39 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +29.4% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +62.3% |
| Market cap (USD) | $135.2M |